Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.44 |
| ▸ | MPO | P05164 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | RAD52 | P43351 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | GAPDH | P04406 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 2/20 | 0.39 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5347326 | 0.74 | HTR2A (0.47) | HTR2AMPOSLC6A4HTR2CKMT2A | |
| SCHEMBL2533034 | 0.74 | HTR2A (0.50) | HTR2AMPOSLC6A4HTR2CKMT2A | |
| Hydrochloric Acid SCHEMBL21546048 | 0.73 | HTR2A (0.49) | HTR2AMPOSLC6A4HTR2CKMT2A | |
| SCHEMBL30712091 | 0.72 | HTR1A (0.68) | HTR2AMPOSLC6A4HTR2CRECQL | |
| SCHEMBL31742617 | 0.69 | HTR2C (0.60) | HTR2AMPOSLC6A4HTR2CRECQL | |
| SCHEMBL25381818 | 0.68 | HTR1A (0.67) | HTR2AMPOHTR2CRECQLMEN1 | |
| SCHEMBL25381712 | 0.68 | HTR2C (0.58) | HTR2AMPOHTR2CRECQLHTR1A | |
| SCHEMBL2537704 | 0.67 | HTR2A (0.59) | HTR2AMPOSLC6A4HTR2CKMT2A | |
| SCHEMBL31730633 | 0.67 | HTR2A (0.59) | HTR2AMPOSLC6A4HTR2CKMT2A | |
| SCHEMBL9407213 | 0.67 | HTR2A (0.57) | HTR2AMPOSLC6A4HTR2CRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270768-A1 | MULTI-SUBSTITUENT PSILOCYBIN DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270768-A1 | MULTI-SUBSTITUENT PSILOCYBIN DERIVATIVES AND METHODS OF USING | CNR2, CNR1, HTR1B | HTR2A 11/4885MPO 4377/4885SLC6A4 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.